Predictive Oncology Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2011 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Predictive Oncology Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2011 to Q3 2024.
  • Predictive Oncology Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$3.09M, a 2.17% increase year-over-year.
  • Predictive Oncology Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$14M, a 24.2% increase year-over-year.
  • Predictive Oncology Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$14M, a 45.7% increase from 2022.
  • Predictive Oncology Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$25.7M, a 30.9% decline from 2021.
  • Predictive Oncology Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$19.7M, a 24.1% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$14M -$3.09M +$68.8K +2.17% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$14M -$3.18M +$742K +18.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-12
Q1 2024 -$14.8M -$4.22M -$797K -23.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-12
Q4 2023 -$14M -$3.48M +$4.44M +56.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 -$18.4M -$3.16M +$896K +22.1% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$19.3M -$3.92M +$6.47M +62.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-12
Q1 2023 -$25.8M -$3.42M -$51.1K -1.52% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-12
Q4 2022 -$25.7M -$7.92M -$160K -2.06% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 -$25.6M -$4.06M +$1.38M +25.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$27M -$10.4M -$7.82M -304% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-13
Q1 2022 -$19.1M -$3.37M +$518K +13.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-13
Q4 2021 -$19.7M -$7.76M +$3.71M +32.4% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-21
Q3 2021 -$23.4M -$5.44M +$870K +13.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$24.2M -$2.57M +$1M +28.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-10
Q1 2021 -$25.2M -$3.89M +$641K +14.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-10
Q4 2020 -$25.9M -$11.5M +$2.08M +15.4% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 -$28M -$6.31M -$2.3M -57.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$25.7M -$3.58M -$5.04M -344% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-10
Q1 2020 -$20.6M -$4.53M -$1.24M -37.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-10
Q4 2019 -$19.4M -$13.6M Oct 1, 2019 Dec 31, 2019 10-K 2021-03-15
Q3 2019 -$4.01M -$1.5M -59.9% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 $1.47M +$3.84M Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-16
Q1 2019 -$3.29M Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-16
Q3 2018 -$2.51M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-15
Q2 2018 -$2.37M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-19
Q2 2015 -$4.89M -$1.19M +$551K +31.7% Apr 1, 2015 Jun 30, 2015 10-Q 2015-08-10
Q1 2015 -$5.44M -$226K +$1.39M +86% Jan 1, 2015 Mar 31, 2015 10-Q 2015-05-18
Q4 2014 -$6.83M -$2.37M -$211K -9.8% Oct 1, 2014 Dec 31, 2014 10-K 2015-04-30
Q3 2014 -$6.62M -$1.12M +$2.86M +71.9% Jul 1, 2014 Sep 30, 2014 10-Q 2014-11-12
Q2 2014 -$9.48M -$1.74M -$560K -47.7% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 -$8.92M -$1.62M +$485K +23.1% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-18
Q4 2013 -$9.41M -$2.15M -$437K -25.4% Oct 1, 2013 Dec 31, 2013 10-K 2015-04-30
Q3 2013 -$8.97M -$3.97M -$1.12M -39.2% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-12
Q2 2013 -$7.85M -$1.18M +$960K +45% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-08
Q1 2013 -$8.81M -$2.1M -$1.39M -195% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
Q4 2012 -$7.42M -$1.72M Oct 1, 2012 Dec 31, 2012 10-K 2014-03-27
Q3 2012 -$2.86M -$2.2M -337% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 -$2.14M -$1.75M -450% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 -$713K Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q3 2011 -$654K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-15
Q2 2011 -$388K Apr 1, 2011 Jun 30, 2011 10-Q/A 2012-08-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.